glp-1 pill With FDA approval of Wegovy pill, new era of oral weight loss drugs begins and trans Novo Nordisk launches Wegovy weight-loss

reimbursable means your specific plan allows the expense

Tell us your population of interest and endpoints

Saxenda (liraglutide) injection, for subcutaneous use: prescribing information

This has a broader population health benefit as greater access to these medicines will reduce the crippling strain obesity-related conditions have on NHS resources. In the UK, generic competition typically reduces prices paid by the NHS by as much as 80% to 90% after loss of exclusivity, according to the BGMA

26,32 Even though the effects of GLP-1 on other tissues are not well characterised, it is becoming increasingly clear that this hormone does have physiological effects on a variety of tissues throughout the body, and a better understanding of the extrapancreatic effects of GLP-1 may have future therapeutic potential for diseases other than T2D